Cyclerion Therapeutics

CYCNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$16.712 M

$3.57 +0.28%

Close of 7 Aug 2026

Revenue

$2.07M

#3427 by revenue

Earnings

-$3.53M

Loss-making

Shares outstanding

4,681,351

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#407LipocineLPCN$17.6M
#408Pasithea TherapeuticsKTTA$16.9M
#409Cyclerion TherapeuticsCYCN$16.7M
#410Medicus PharmaMDCX$16.5M
#411Optimi HealthOPTH$16.3M

Where these numbers come from

Share counts and financials for Cyclerion Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.